3B Blackbio DX Ltd
Ticker: 3BBLACKBIO
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
1372.10
Market Cap
1177.63
Debt/Equity
0.0011
ROE %
19.212
PB
4.3455
Promoter %
41.283
Pledge %
0.000
1Y Rev Growth %
28.736
5Y Rev Growth %
29.634
NP Margin %
42.752
NP Margin 5Y Avg %
40.741
Trading Reference
1M Return %
-2.518
6M Return %
-22.366
1Y Return %
2.995
% Away 52W High
71.270
% Away 52W Low
6.241
Daily Volume
2491
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
3B Blackbio DX Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above recent resistance. Volume has been increasing, suggesting growing investor interest. Therefore, there is a favorable outlook for the next 6-12 months, with a potential upside if momentum continues.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Benares Hotels Ltd
Benares Hotels Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
A
Amines and Plasticizers Ltd
Amines and Plasticizers Ltd shows decent potential but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
P
Pudumjee Paper Products Ltd
Pudumjee Paper Products Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
A
A B Infrabuild Ltd
A B Infrabuild Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
T
Texmaco Infrastructure & Holdings Ltd
Texmaco Infrastructure & Holdings Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
M
Manali Petrochemicals Ltd
Manali Petrochemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
M
Meghna Infracon Infrastructure Ltd
Meghna Infracon Infrastructure Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sterling Tools Ltd
Sterling Tools Ltd shows decent potential but faces challenges in profitability and valuation. Investors should be cautious.
View details
K
Krishna Defence & Allied Industries Ltd
The company operates in a promising sector but faces significant risks and inconsistencies in performance metrics.
View details
B
BCL Industries Ltd
BCL Industries Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
P
Panorama Studios International Ltd
Panorama Studios International Ltd shows potential in a growing sector but faces significant risks in execution and financial stability.
View details
A
Asian Star Co Ltd
Asian Star Co Ltd shows potential but faces significant risks that may hinder its growth and profitability.
View details
C
Cosmic CRF Ltd
Cosmic CRF Ltd shows potential but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
I
India Power Corporation Ltd
India Power Corporation Ltd shows potential but faces significant challenges in growth consistency and profitability, making it a cautious investment.
View details
P
Peninsula Land Ltd
Peninsula Land Ltd presents several risks with inconsistent growth and profitability metrics, alongside high debt levels, making it a risky investment at this time.
View details
B
Bluspring Enterprises Ltd
Bluspring Enterprises Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
AI Technical Snapshot
The stock is currently in a bearish trend, trading below the key moving averages.
Trend: Bearish
Supports: 1310, 1200
Resistances: 1675, 1500
MAs: 200-SMA, 50-SMA
Scenarios:
If price breaks above 1500, it may signal a trend reversal towards 1675. • If it breaks down below 1300, further decline towards 1200 is possible.
Invalidation: Close below 1300 would confirm a continuation of the bearish trend.
Risk: Volatile price action observed; exercise caution due to potential false breakouts.
Suggested Plan (edu.)
Consider shorting near resistance at 1500; look to buy only if reclaiming 1500 with bullish volume.
Educational only — not investment advice.
Business Overview
3B Blackbio DX Ltd is a pioneering biotechnology company based in India, specializing in advanced diagnostic solutions. Catering to healthcare providers, research institutions, and laboratories, the company focuses on enhancing patient care through innovative diagnostics. With a commitment to quality and accuracy, 3B Blackbio DX Ltd plays a crucial role in the early detection of diseases, ultimately improving health outcomes. Their cutting-edge technology and robust product portfolio position them as a leader in the Indian diagnostics market, making them a trusted partner in healthcare advancement.
- Pioneering biotechnology firm in India
- Focus on advanced diagnostic solutions
- Serves healthcare providers and research institutions
- Enhances patient care through innovative diagnostics
- Commitment to quality and accuracy
- Leader in the Indian diagnostics market
Investment Thesis
3B Blackbio DX Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth in the evolving diagnostics market.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with industry trends.
- Attractive valuation metrics compared to industry peers signal potential upside.
- Robust demand for diagnostic services supports long-term revenue growth.
- Strategic investments in technology position the company for future success.
Opportunity vs Risk
Opportunities
- Growing demand for diagnostic solutions
- Expansion into international markets
- Strong R&D pipeline
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory changes impacting operations
- High competition in diagnostics sector
- Dependence on key customers
- Market volatility affecting stock price
Peer Perspective
3B Blackbio DX Ltd trades at a discount to peers like Dr. Lal PathLabs and Thyrocare, primarily due to concerns over margin stability. A consistent improvement in margins could trigger a rerating.
Future Outlook
3B Blackbio DX Ltd is well-positioned for growth, driven by innovation in diagnostics. Successful execution of its strategic initiatives and effective cost control will be crucial to maximize shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does 3B Blackbio DX Ltd do?A: 3B Blackbio DX Ltd specializes in providing diagnostic solutions and medical devices.
- Q: Is 3B Blackbio DX Ltd listed on Indian stock exchanges?A: Yes, it is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
- Q: What factors influence the stock price of 3B Blackbio DX Ltd?A: Stock price can be influenced by market trends, company performance, and industry developments.
- Q: How can I invest in 3B Blackbio DX Ltd?A: You can invest through a brokerage account by purchasing shares on the stock exchanges.
- Q: What are the risks of investing in 3B Blackbio DX Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
3B Blackbio DX Ltd • Updated: 2025-09-16 19:07:17
-
10BusinessHighThe company operates in the diagnostics sector, which is growing but faces competition.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow issues affecting net profit.
-
8ValuationHighValuation metrics are above industry averages, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity affecting price action.
Final Score & Verdict
Score 66 / 100
• Decent
3B Blackbio DX Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100